Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome

Autor: Magnani, A., Semeraro, M., Adam, F., Booth, C., Dupré, L., Morris, E. C., Gabrion, A., Roudaut, C., Borgel, D., Toubert, A., Clave, E., Abdo, C., Gorochov, G., Petermann, R., Guiot, M., Miyara, M., Moshous, D., Magrin, E., Denis, A., Suarez, F., Lagresle, C., Roche, A. M., Everett, J., Trinquand, A., Guisset, M., Bayford, J. Xu, Hacein-Bey-Abina, S., Kauskot, A., Elfeky, R., Rivat, C., Abbas, S., Gaspar, H. B., Macintyre, E., Picard, C., Bushman, F. D., Galy, A., Fischer, A., Six, E., Thrasher, A. J., Cavazzana, M.

Publikováno v: NATURE MEDICINE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
Nature Medicine
Nature Medicine, 2022, 28 (1), pp.71-80. ⟨10.1038/s41591-021-01641-x⟩

Patients with Wiskott–Aldrich syndrome (WAS) lacking a human leukocyte antigen-matched donor may benefit from gene therapy through the provision of gene-corrected, autologous hematopoietic stem/progenitor cells. Here, we present comprehensive, long

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3f98b89d4b68a773ab2a2e9643726a
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=21058

Using a KDD process to forecast the duration of surgery

Autor: Combes, C., Meskens, N., Rivat, C., Vandamme, J.-P.

Publikováno v: In International Journal of Production Economics 2008 112(1):279-293

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

APRIL-mediated anti-inflammatory response of astrocytes in multiple sclerosis

Autor: Baert, L., Benkhoucha, M., Popa, N., Ahmed, M., Manfroi, B., Boutonnat, J., Sturm, N., Raguenez, G., Tessier, M., Casez, Olivier, Marignier, R., Ahmadi, M., Broisat, A., Ghezzi, C., Rivat, C., Sonrier, C., Hahne, M., Baeten, D., Vives, R., Lortat-Jacob, Hugues, Marche, N., Schneider, P., Lassmann, H., Boucraut, J., Lalive, P., Huard, B.

Publikováno v: Annals of Neurology
Annals of Neurology, Wiley, 2019, ⟨10.1002/ana.25415⟩

International audience; OBJECTIVE:the two related TNF members APRIL and BAFF are currently targeted in autoimmune diseases as B-cell regulators. In multiple sclerosis (MS), combined APRIL/BAFF blockade led to an unexpected exacerbated inflammation in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d9902c364cefe6c6faf367f715361499
https://hal.archives-ouvertes.fr/hal-01989068